Research conducted by Shi W et al. showed that HER2 promotes cell mitosis by activating the HER2-SHCBP1-PLK1 axis, thereby influencing the development of GC and the sensitivity to trastuzumab29. Here, SHCBP1 is linked to gastric cancer.